Cambridge Investment Research Advisors’s AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF SIXD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Sell
10,624
-755
-7% -$22.8K ﹤0.01% 3369
2026
Q1
$322K Sell
11,379
-7,233
-39% -$209K ﹤0.01% 3224
2025
Q4
$538K Buy
18,612
+41
+0.2% +$1.17K ﹤0.01% 2649
2025
Q3
$526K Sell
18,571
-5,534
-23% -$154K ﹤0.01% 2632
2025
Q2
$661K Sell
24,105
-39,578
-62% -$1.05M ﹤0.01% 2287
2025
Q1
$1.67M Buy
+63,683
New +$1.7M 0.01% 1466

Other funds holding SIXD

Cambridge Investment Research Advisors's SIXD Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF (SIXD) stake by 6.6% in Q2 2026, selling an estimated $22.8K and leaving 10,624 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #3369.

Cambridge Investment Research Advisors first reported a position in SIXD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.67M in Q1 2025. 55 funds tracked by Wall St. Rank hold SIXD as of Q2 2026.

  • Cambridge Investment Research Advisors held 10,624 shares of AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF worth $328K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 755 AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF shares in Q2 2026, an estimated $22.8K.
  • AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3369 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF in Q1 2025 and has held it in 6 quarters since.
  • Cambridge Investment Research Advisors's AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF position peaked at $1.67M in Q1 2025.
  • 55 funds tracked by Wall St. Rank held AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.